Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 7:35:100701.
doi: 10.1016/j.bbih.2023.100701. eCollection 2024 Feb.

SARS-CoV-2 infection and cognition in community-dwelling and nursing home residents in southern Switzerland

Greta Rizzi  1 , Deborah Pacifico  1 , Serena Sabatini  2 , Anna Maria Annoni  1 , Federico Mele  3 , Sandra Jovic  3 , Luca Piccoli  4 , Laurie Corna  5 , Rebecca Amati  1 , William Pertoldi  6 , Maddalena Fiordelli  1 , Federica Sallusto  3   7 , Emiliano Albanese  1
Affiliations

SARS-CoV-2 infection and cognition in community-dwelling and nursing home residents in southern Switzerland

Greta Rizzi et al. Brain Behav Immun Health. .

Abstract

Background: COVID-19 patients can report 'brain fog' and may exhibit cognitive symptoms for months after recovery (Cognitive COVID). However, evidence on whether and the extent to which SARS-CoV-2 infection impacts cognition irrespective of COVID-19 course and severity is limited to clinical samples and mainly comes from prognostic studies. We aimed to explore the association between serologically confirmed SARS-CoV-2 infection and cognitive functioning in community-based and institutionalized older adults, irrespective of COVID-19 symptoms.

Methods: We conducted a case-control study nested into two cohorts in Southern Switzerland. Eligible subjects were Italian speaking older adults, without a previous diagnosis of dementia, who underwent serological testing for anti-SARS-CoV-2 antibodies between November 2020 and July 2021. We manually selected age-, sex- and education-matched cases (i.e., individuals with a serologically confirmed SARS-CoV-2 infection), with seronegative controls, and we conducted in-person neuropsychological assessments using validated, highly sensitive cognitive tests.

Results: We completed 38 neuropsychological assessments in a mostly female sample of older adults (Mean age: 83.13 ± 8.95; 86.8% women). 17 were community dwelling individuals while 21 lived in a nursing home. As expected, socio-demographic characteristics of age, gender and educational level were similarly distributed between cases (n = 14) and controls (n = 24). In linear regression models, cases had significantly lower scores in cognitive tasks of memory (β = -0.367, p = 0.023), attention (β = 0.428, p = 0.008) and executive functions (β = 0.326, p = 0.046). We found no significant difference in tests of language and spatial-temporal orientation (all p values > 0.05).

Conclusions: SARS-CoV-2 infection was associated with cognitive impairment in memory, attention, and executive functions in older adults. Our findings are consistent with mechanistic evidence of the neurotropism of the virus and provide empirical support for the "Cognitive COVID" construct also in non-clinical samples. With nearly 800 million COVID-19 cases (in April 2023), and many more infections worldwide, the clinical and public health implications of Cognitive COVID due to SARS-CoV-2 infection may be massive and warrant further epidemiological investigations.

Keywords: Cognitive COVID; Cognitive decline; Long COVID; Neuropsychological assessment; SARS-CoV-2 infection; Serological assessment.

PubMed Disclaimer

Conflict of interest statement

The authors have no declaration of competing interest.

References

    1. Alemanno F., Houdayer E., Parma A., Spina A., Del Forno A., Scatolini A., Angelone S., Brugliera L., Tettamanti A., Beretta L., Iannaccone S. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. 2021;16(2) doi: 10.1371/journal.pone.0246590. - DOI - PMC - PubMed
    1. Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain, Behavior, & Immunity - Health. 2020;9 doi: 10.1016/j.bbih.2020.100163. - DOI - PMC - PubMed
    1. Amati R., Piumatti G., Franscella G., Buttaroni P., Camerini A.-L., Corna L., Levati S., Fadda M., Fiordelli M., Annoni A.M., Bezani K., Amendola A., Fragoso Corti C., Sabatini S., Kaufmann M., Frei A., Puhan M.A., Crivelli L., Albanese E., on behalf of the Corona Immunitas Ticino Study Group Trajectories of seroprevalence and neutralizing activity of antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: an ongoing, prospective population-based cohort study. Int. J. Environ. Res. Publ. Health. 2023;20(4):3703. doi: 10.3390/ijerph20043703. - DOI - PMC - PubMed
    1. Batty G.D., Deary I.J., Luciano M., Altschul D.M., Kivimäki M., Gale C.R. Psychosocial factors and hospitalisations for COVID-19: prospective cohort study based on a community sample. Brain Behav. Immun. 2020;89:569–578. doi: 10.1016/j.bbi.2020.06.021. - DOI - PMC - PubMed
    1. Beaud V., Crottaz-Herbette S., Dunet V., Vaucher J., Bernard-Valnet R., Du Pasquier R., Bart P.-A., Clarke S. Pattern of cognitive deficits in severe COVID-19. J. Neurol. Neurosurg. Psychiatr. 2021;92(5):567–568. doi: 10.1136/jnnp-2020-325173. - DOI - PMC - PubMed